Sertraline effects on dyspnea in patients with obstructive airways disease (Q39449450)

12 September 2017

Sertraline effects on dyspnea in patients with obstructive airways disease (English)

1 reference

12 September 2017

0 references

1 reference

1

Smoller JW

1 reference

12 September 2017

4

Kradin RL

1 reference

12 September 2017

Pollack MH

2

1 reference

PubMed ID

9538672

12 September 2017

Systrom D

series ordinal

3

1 reference

12 September 2017

1 January 1998

1 reference

12 September 2017

1 reference

12 September 2017

39

1 reference

12 September 2017

1

1 reference

12 September 2017

24-29

1 reference

The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Higher lifetime prevalence of respiratory diseases in panic disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Carbon dioxide hypersensitivity, hyperventilation, and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Evidence that respiratory depression by serotonin agonists may be exerted in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Effects of serotonin and substance P on bulbar respiratory neurons in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Serotonergic influences on central respiratory activity: an in vitro study in the newborn rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Panic disorder patients show decrease in ventilatory response to CO2 after clomipramine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Buspirone, an anxiolytic drug that stimulates respiration

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Effects of buspirone on sleep and respiration.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Buspirone for anxiety disorders in patients with severe lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Buspirone for the treatment of anxiety in patients with chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Effect of desipramine on control of ventilation and depression scores in patients with severe chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Newer antidepressants and the cytochrome P450 system

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

Psychological Aspects of Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971377-5

7 January 2021

10.1016/S0033-3182(98)71377-5

Identifiers

DOI

0 references

PubMed ID

9538672

1 reference

PubMed ID

9538672